Literature DB >> 27766679

Hemodialysis Time and Kt/V: Less May Be Better.

James Tattersall1.   

Abstract

Current guidelines focus on conventional dialysis defined as 3-5 hours, three times per week, and suggest that longer or more frequent dialysis be considered. This paper presents the case for considering that shorter or less frequent dialysis should also be considered. More frequent and/or longer dialysis facilitates control of fluid overload, blood pressure, and phosphate levels. These benefits will require time to translate into probable hard outcome improvement. Patients are unlikely to participate in productive or pleasurable activities while undergoing dialysis in center or traveling to treatment. So any increase in dialysis time or frequency, during awake hours, will result in an immediate and quantifiable reduction in quality of life. Conventional measures of dialysis adequacy consider only urea clearance. This poorly reflects middle molecule clearance, renal function, and management of fluid and phosphate overload, all of which have a greater impact on outcome than urea clearance. Fluid, phosphate, and uremic toxin overload may be better and less invasively controlled by continuous means such as dietary modification, binders, and preserving renal function. Bioimpedance, blood volume monitoring, and lung ultrasound provide means for improved control of fluid homeostasis. The probability of renal function recovery or preservation is increased by avoiding dehydration. An ideal strategy would be to preserve renal function and employ as little dialysis as possible (if it cannot be avoided altogether). Fluid overload, blood pressure, uremic toxin, and phosphate levels would be monitored and controlled using any means available, preferably by less invasive means than dialysis. Kt/V is useful in controlling the prescribed dose of dialysis, but the achievement of a universal target should not be an end in itself.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27766679     DOI: 10.1111/sdi.12555

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  6 in total

Review 1.  Single needle hemodialysis: is the past the future?

Authors:  Raymond Vanholder
Journal:  J Nephrol       Date:  2019-09-19       Impact factor: 3.902

Review 2.  Choices in hemodialysis therapies: variants, personalized therapy and application of evidence-based medicine.

Authors:  Bernard Canaud; Stefano Stuard; Frank Laukhuf; Grace Yan; Maria Ines Gomez Canabal; Paik Seong Lim; Michael A Kraus
Journal:  Clin Kidney J       Date:  2021-12-27

3.  Incremental and Personalized Hemodialysis Start: A New Standard of Care.

Authors:  Massimo Torreggiani; Antioco Fois; Antoine Chatrenet; Louise Nielsen; Lurlynis Gendrot; Elisa Longhitano; Léna Lecointre; Claudine Garcia; Conrad Breuer; Béatrice Mazé; Assia Hami; Guillaume Seret; Patrick Saulniers; Pierre Ronco; Frederic Lavainne; Giorgina Barbara Piccoli
Journal:  Kidney Int Rep       Date:  2022-02-19

4.  Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine.

Authors:  Jeung-Min Park; Jong-Hak Lee; Hye Min Jang; Yeongwoo Park; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Eugene Kwon; Hyun-Ji Kim; Ji-Eun Lee; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Jang-Hee Cho; Yong-Lim Kim
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

Review 5.  Assessment of dialysis adequacy: beyond urea kinetic measurements.

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2018-03-26       Impact factor: 3.714

6.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.